Influence of glycemic control and hypertension on urinary microprotein excretion in non-insulin-dependent diabetes mellitus.
In order to evaluate the influence of glycemic control and hypertension on the development of diabetic nephropathy, we measured urinary excretion of albumin (AER) and other microproteins in non-insulin-dependent diabetes mellitus (NIDDM), and reexamined the 103 patients who had had AER less than 300 micrograms/min at the initial study 12-18 months later. AER in the patients with HbA1c greater than or equal to 7.5% increased significantly in both the normoalbuminuric (AER less than 30 micrograms/min) and microalbuminuric (30-300 micrograms/min) groups, whereas no significant change in AER was observed in the patients with HbA1c less than 7.5%. In the microalbuminuric group, AER in both hypertensive and normotensive patients increased significantly. In this group, the change in AER correlated positively with the change in alpha 1-microglobulin (alpha 1M). These results indicate that glycemic control has a greater influence on the development of nephropathy in its early stage than hypertension and that alpha 1M is as a good predictor of nephropathy as albumin.
Wainai
H
H
Department of Internal Medicine, School of Medicine, Keio University, Tokyo, Japan.
Katsukawa
F
F
Takei
I
I
Maruyama
H
H
Kataoka
K
K
Saruta
T
T
D000118:Acetylglucosaminidase / Q000652:urine; D000419:Albuminuria; D000510:Alpha-Globulins / Q000652:urine; D015415:Biomarkers / Q000652:urine; D001786:Blood Glucose / Q000378:metabolism; D003924:Diabetes Mellitus, Type 2 / Q000097:blood / Q000503:physiopathology* / Q000652:urine; D003928:Diabetic Nephropathies / Q000503:physiopathology*; D005500:Follow-Up Studies; D006442:Glycated Hemoglobin / Q000032:analysis*; D006801:Humans; D006973:Hypertension / Q000150:complications / Q000503:physiopathology*; D008875:Middle Aged; D011480:Protease Inhibitors / Q000652:urine; D011507:Proteinuria; D001613:beta 2-Microglobulin / Q000652:urine
D000118:Acetylglucosaminidase; D000510:Alpha-Globulins; D015415:Biomarkers; D001786:Blood Glucose; D006442:Glycated Hemoglobin; D011480:Protease Inhibitors; D001613:beta 2-Microglobulin; C016001:alpha-1-microglobulin